Avantor: Turnaround and Price Target Increases Drive Stock to Yearly High!
Reading Time: 2 minutes
Price target increases from BofA, TD Cowen, Morgan Stanley, and Barclays trigger a buying wave: On October 16, three times the usual volume changes hands, marking a yearly high for the stock. The recovery in the life sciences sector provides a tailwind, with industry leader Thermo Fisher reporting on October 21. The turnaround program "Revival" is taking effect, and the forecast has been raised. Avantor supplies laboratories and production facilities in the biopharma industry, healthcare, and high technology with everything that keeps...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
